PSA Testing in Prostate Cancer: Early Treatment vs Observation
In this interview we discuss the role of early treatment, active surveillance, and watchful waiting in patients with PSA-detected early-stage prostate cancer.
Baseline PSA Testing for Men in Their 40s: Testing in Average-Risk Men Aged 40 to 50 Years Should Not Be Routinely Performed
Many urologists believe that all men, regardless of risk, should be offered a baseline prostate-specific antigen (PSA) test at age 40 years. I was once one of those urologists.